NAAA and autoimmune thrombocytopenic purpura: Inspired by the characteristics of platelets in immune thrombocytopenia that are easily phagocytosed by macrophages, this study designs and constructs anti‐CD41‐PLT‐VP16 for targeting abnormally activated macrophages in hemophagocytic lymphohistiocytosis (HLH).